SCOPUS 정보 검색 플랫폼

Volumn 18, Issue 2, 2008, Pages 73-76

For the proposition: For the diagnosis of viral infections, commercial assays provide more reliable results than do in-house assays

(1) Gammie, Alistair James a,b,c

a Bayer House (United Kingdom)

b Newton House (United Kingdom)

c European Marketing

Author keywords

[No Author keywords available]

Indexed keywords

ASSAY; FOOD AND DRUG ADMINISTRATION; INFLUENZA; INFLUENZA VIRUS A H5N1; MOLECULAR BIOLOGY; QUALITY CONTROL; REVIEW; STANDARDIZATION; VIRUS INFECTION;

GENETIC TECHNIQUES; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; REAGENT KITS, DIAGNOSTIC; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; VIROLOGY; VIRUS DISEASES;

EID: 41149116191 PISSN: 10529276 EISSN: None Source Type: Journal
DOI: 10.1002/rmv.564 Document Type: Review

Times cited : (4)

References (10)

1
- 84872365497
- The WHO website http://www.who.int/immunization/topics/hepatitis_c/en/ index.html
- The WHO website

2
- 2542479703
- Burden of illness of hepatitis C from a managed care organization perspective
- Armstrong EP, Charland SL. Burden of illness of hepatitis C from a managed care organization perspective. Curr Med Res Opin 2004; 20(5): 671-679.
- (2004) Curr Med Res Opin , vol.20 , Issue.5 , pp. 671-679
- Armstrong, E.P.¹ Charland, S.L.²

3
- 41149113207
- December 01, 2005
- MedPage Today, Hepatitis C Healthcare Costs Rising as Patients Age http://www.medpagetoday.com/InfectiousDisease/Hepatitis/tb/2246 [December 01, 2005].
- MedPage Today, Hepatitis C Healthcare Costs Rising as Patients Age

4
- 0031748381
- Health care costs of a continuing epidemic of hepatitis C virus infection among injecting drug users
- Brown K, Crofts N. Health care costs of a continuing epidemic of hepatitis C virus infection among injecting drug users. Aust NZJ Public Health 1998; 22(3 Suppl): 384-388.
- (1998) Aust NZJ Public Health , vol.22 , Issue.3 SUPPL. , pp. 384-388
- Brown, K.¹ Crofts, N.²

5
- 6044268124
- Modelling the healthcare costs of an opportunistic chlamydia screening programme
- Adams EJ, LaMontagne DS, Johnston AR, Pimenta JM, Fenton KA, Edmunds WJ. Modelling the healthcare costs of an opportunistic chlamydia screening programme. Sex Transm Infect 2004; 80: 363-370.
- (2004) Sex Transm Infect , vol.80 , pp. 363-370
- Adams, E.J.¹ LaMontagne, D.S.² Johnston, A.R.³ Pimenta, J.M.⁴ Fenton, K.A.⁵ Edmunds, W.J.⁶

6
- 0037329660
- Spending money to save money
- doi:10.1136/sti.79.1.4
- Mehta SD, Shahmanesh M, Zenilman JM. Spending money to save money. Sex Transm Inf 2003; 79: 4-6. doi:10.1136/sti.79.1.4.
- (2003) Sex Transm Inf , vol.79 , pp. 4-6
- Mehta, S.D.¹ Shahmanesh, M.² Zenilman, J.M.³

7
- 41149097380
- The UK Collaborative Group for HIV and STI Surveillance. Mapping the Issues
- Health Protection Agency, London: Health Protection Agency Centre for Infections
- Health Protection Agency. The UK Collaborative Group for HIV and STI Surveillance. Mapping the Issues. HIV and other Sexually Transmitted Infections in the United Kingdom: 2005. London: Health Protection Agency Centre for Infections, 2005.
- (2005) HIV and other Sexually Transmitted Infections in the United Kingdom

8
- 41149104237
- The FDA website
- The FDA website. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/ CFRSearch.cfm?fr=864.4020

9
- 41149132022
- Conformity Assessment Procedures under the in vitro Diagnostic medical devices directive 98/79/EC, Bulletin No. 20, Competent Authority(UK) Amended January 2006.
- Conformity Assessment Procedures under the in vitro Diagnostic medical devices directive 98/79/EC, Bulletin No. 20, Competent Authority(UK) Amended January 2006.

10
- 41149084320
- EC medical devices directives, Guidance notes on in vitro Diagnostic medical devices, directive 98/79/EC Amended February 2006.
- EC medical devices directives, Guidance notes on in vitro Diagnostic medical devices, directive 98/79/EC Amended February 2006.

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.